Trinity Capital Inc.近日宣布与Neuros Medical达成战略合作，双方将共同加速Altius神经调控系统的商业化进程，并计划开拓新的医疗市场领域。此次合作标志着Trinity Capital在医疗科技投资布局的进一步深化，旨在通过技术创新为慢性疼痛患者提供更精准的非药物治疗方案。据悉，Altius系统采用独特的电刺激技术，能够靶向调节周围神经系统功能，目前已在美国部分医疗机构开展临床应用。此次市场拓展将重点关注欧洲和亚太地区未满足的临床需求，预计首批商业化试点将于明年下半年启动。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.